Showing results (191-200 of 354) with videos related to
Sort By:
Pageof 36
Transplantation Proceedings|January 3, 2006
Correlation between cyclosporine-induced nephrotoxicity in reduced nephron mass and expression of kidney injury molecule-1 and aquaporin-2 geneM E Hong, J C Hong, S Stepkowski, et al.Japanese Journal of Cancer Research : Gann|November 1, 1989
Active specific chemoimmunotherapy of lymph-node metastasis from a poorly immunogenic murine fibrosarcomaK Naito, T Oka, S Nomi, et al.European Journal of Clinical Pharmacology|January 1, 1993
On the intraindividual variability and chronobiology of cyclosporine pharmacokinetics in renal transplantationS Ohlman, A Lindholm, H Hägglund, et al.Cancer|March 15, 1982
Immunotherapeutic effects of tumor-specific transplantation antigens released by 1-butanolB D Kahan, N R Pellis, S J LeGrue, et al.Journal of Clinical Immunology|July 1, 1981
Serial measurement of nonspecific immune parameters in chronically hemodialyzed renal failure patientsR H Kerman, M Floyd, C Van Buren, et al.Journal of Clinical Pharmacology|March 1, 1989
Influence of demographic factors on cyclosporine pharmacokinetics in adult uremic patientsJ Grevel, K L Reynolds, L P Rutzky, et al.Pharmacotherapy|December 17, 1997
Sirolimus, a new, potent immunosuppressive agentP A Kelly, S A Gruber, F Behbod, et al.Transplantation|June 1, 1988
Prevention of alloantibody formation after skin grafting without prolongation of graft survival by anti-L3T4 in vivoH Auchincloss, R R Ghobrial, P S Russell, et al.Transplantation Proceedings|March 22, 2006
Individualization of immunosuppressive therapy. III. Sirolimus associated with a reduced incidence of malignancyY K Yakupoglu, J F Buell, S Woodle, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|March 21, 1998
Impact of early cyclosporin average blood concentration on early kidney transplant failureM F Senel, C T Van Buren, M Welsh, et al.Pageof 36